RA Capital Management, L.P. 13D and 13G filings for TG Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-10 4:49 pm Sale | 2021-01-31 | 13G | TG Therapeutics, Inc. TGTX | RA Capital Management, L.P. | 6,361,123 4.700% | -2,324,348![]() (-26.76%) | Filing |
2021-02-10 4:34 pm Sale | 2020-12-31 | 13G | TG Therapeutics, Inc. TGTX | RA Capital Management, L.P. | 8,685,471 6.400% | -4,102,986![]() (-32.08%) | Filing |
2020-06-10 4:15 pm Purchase | 2020-05-31 | 13G | TG Therapeutics, Inc. TGTX | RA Capital Management, L.P. | 12,788,457 10.800% | 2,908,134![]() (+29.43%) | Filing |